Oriol Turró-Garriga1,2, Josep Garre-Olmo1,3, Ramon Reñé-Ramírez4, Laia Calvó-Perxas1, Jordi Gascón-Bayarri4, Josep-Lluís Conde-Sala1,5. 1. Aging, Disability and Health Research Group, Girona Biomedical Research Institute [IdIBGi], Catalonia, Spain. 2. Department of Neurology, Dementia Unit, Institut d'Assistència Sanitária, Salt, Catalonia, Spain. 3. Department of Medical Sciences, University of Girona, Catalonia, Spain. 4. Department of Neurology, Dementia Unit, Bellvitge University Hospital, Hospitalet de Llobregat, Catalonia, Spain. 5. Faculty of Psychology, University of Barcelona, Catalonia, Spain.
Abstract
BACKGROUND: Anosognosia is common in patients with Alzheimer's disease (AD) and it is frequently related to an increase in time of care demand. OBJECTIVE: The aim of the study was to examine the effect of anosognosia on the total costs of informal care in patients with AD. METHODS: This was a prospective longitudinal study with community-dwelling AD patients. Anosognosia, time of informal care, and the use of support services (e.g., day care centers) were recorded at baseline and after 24 months. The cost of informal caregiving was calculated as 'market price'. RESULTS: At baseline, the prevalence of anosognosia was 54.3% (n = 221), and 43.9% were classified as mild-AD. The average time of care was 5 h/day±2.4 (IADL: 1.3 h/day±1.4 and BADL: 3.6 h/day±1.5). Thirty percent of the patients used home care services, and 25.1% attended a day care center. Patients with anosognosia received more time of care and were more likely to use support services than did their no-anosognosia peers, including institutionalization. The mean cost of support services was 490.4€ /month (SD = 413.1€; range = 25-2,212.38€), while the overall cost of care (support services plus informal care) was 1,787€ /month (SD = 972.4€), ranging from 834.1€ in mild-AD without anosognosia patients, to 2,424.8€ in severe-AD with incident anosognosia patients. CONCLUSIONS: Anosognosia was associated with an increased number of hours of informal care, and a greater use of support services, regardless of the severity of the dementia, which lead to an increase of the total family-care costs.
BACKGROUND:Anosognosia is common in patients with Alzheimer's disease (AD) and it is frequently related to an increase in time of care demand. OBJECTIVE: The aim of the study was to examine the effect of anosognosia on the total costs of informal care in patients with AD. METHODS: This was a prospective longitudinal study with community-dwelling ADpatients. Anosognosia, time of informal care, and the use of support services (e.g., day care centers) were recorded at baseline and after 24 months. The cost of informal caregiving was calculated as 'market price'. RESULTS: At baseline, the prevalence of anosognosia was 54.3% (n = 221), and 43.9% were classified as mild-AD. The average time of care was 5 h/day±2.4 (IADL: 1.3 h/day±1.4 and BADL: 3.6 h/day±1.5). Thirty percent of the patients used home care services, and 25.1% attended a day care center. Patients with anosognosia received more time of care and were more likely to use support services than did their no-anosognosia peers, including institutionalization. The mean cost of support services was 490.4€ /month (SD = 413.1€; range = 25-2,212.38€), while the overall cost of care (support services plus informal care) was 1,787€ /month (SD = 972.4€), ranging from 834.1€ in mild-AD without anosognosiapatients, to 2,424.8€ in severe-AD with incident anosognosiapatients. CONCLUSIONS:Anosognosia was associated with an increased number of hours of informal care, and a greater use of support services, regardless of the severity of the dementia, which lead to an increase of the total family-care costs.
Entities:
Keywords:
Alzheimer’s disease; anosognosia; cost of illness; dementia; health care costs; longitudinal studies
Authors: Bernard J Hanseeuw; Matthew R Scott; Sietske A M Sikkes; Michael Properzi; Jennifer R Gatchel; Eric Salmon; Gad A Marshall; Patrizia Vannini Journal: Ann Neurol Date: 2019-12-05 Impact factor: 10.422
Authors: Patrizia Vannini; Bernard J Hanseeuw; Jennifer R Gatchel; Sietske A M Sikkes; Diana Alzate; Yesica Zuluaga; Sonia Moreno; Luis Mendez; Ana Baena; Paula Ospina-Lopera; Victoria Tirado; Eliana Henao; Natalia Acosta-Baena; Margarita Giraldo; Francisco Lopera; Yakeel T Quiroz Journal: JAMA Netw Open Date: 2020-12-01
Authors: Patrizia Vannini; Federico d'Oleire Uquillas; Heidi I L Jacobs; Jorge Sepulcre; Jennifer Gatchel; Rebecca E Amariglio; Bernard Hanseeuw; Kathryn V Papp; Trey Hedden; Dorene M Rentz; Alvaro Pascual-Leone; Keith A Johnson; Reisa A Sperling Journal: Neuroimage Clin Date: 2019-11-18 Impact factor: 4.881